European researchers advance bone implants technology

European researchers are relentless in their pursuit to develop technologies across the board. Case in point is medical technology and bone implants. Enter a team of researchers from the Germany-based Fraunhofer Institute for Manufacturing Engineering and Applied Materials Research who have developed a simulation programme calculating the internal structure and density distribution of bone material.

The production of bone implants with a structure similar to natural bone is being produced easily. The initial step in this process is the calculation of the bone's internal structure and porosity, followed by the 'baking' of the implant from metal powder. The second step is conducted in a prototyping machine.

Scientists involved in the production of bone implants look to nature for resources, taking a close look at the structure of bone and how it is constructed. While bones are light, they have the capacity to tolerate strong loads. Also, the interior of bone is sponge-like but firm and compact in some areas.

With this in mind, the Fraunhofer team rose to the challenge of the lightweight construction industry which asked 'How can this be replicated?' The researchers successfully developed a simulation programme that shows how bone structure must be constructed in order to meet the specified requirements.

This latest development gives engineers the means to produce complex components with the help of rapid prototyping technology. The process focuses on coating a surface with wafer-thin layers of special metal powder. A laser beam sinters (heats without melting) ores or powdery metals into a coherent mass in the areas that must be firm.

"It's like baking a cake," explains Andreas Burblies, a representative for the Fraunhofer Numerical Simulation of Products, Processes Alliance. "The end product is an open-pored element. Any remaining loose powder is then removed. Each point possesses exactly the right density and thus also a certain stability," he adds.

Engineers can now make lightweight components that are tailor-made for each application. The upshot is that these components will be able to withstand heavy loads. The research team has also given the engineers the means to change the internal structure of the parts once they are produced through precision drilling.

"We can manufacture and adapt the parts exactly as required," Mr Burblies says. Experts have said that the production of individual implants with an internal structure that is similar to a patient's bone is not difficult. Biomaterials-based metal powders, like steel alloys and titanium, give engineers an edge because reconstruction of other bone elements is made easy. This innovative technique will draw in several industries, including bone implants production, and aircraft and automobile manufacturers.

For more information, please visit:
http://www.ifam.fraunhofer.de

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

WHO grants prequalification to GSK's Mosquirix - t…

GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking mala...

Bird's enzyme points toward novel therapies

Thank the rare crested ibis for a clue that could someday help our bodies make better drugs. The species of bird is the only one known to naturally produce an enzyme ...

WHO strongly advises against antibody treatments f…

The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19, says a WHO Guideline Development Group of international experts in...